Exosome Diagnostic and Therapeutics Market Demand, Analysis & Forecast

1

Exosome Diagnostic and Therapeutics Market By
Size, Demand Analysis, Type, Statistics, Regions
and Forecast 2027 FMI

• May 2021

Report Id    REP-GB-6379Published On    
2018-02-20 Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Exosome Diagnostic and Therapeutics Market
Analysis
Future Market Insights in its recent research
report titled Exosome Diagnostic and
Therapeutics Market Global Industry Analysis
(2012-2016) and Opportunity Assessment
(2017-2027) covers several factors that are
influencing the robust growth of the global
market. As per this research report, the global
exosome diagnostic and therapeutic market is
projected to expand at a high CAGR of 23.1
during the period of assessment. The exhaustive
research publication includes key trends,
opportunities, threats, growth drivers and
challenges that impact the global exosome
diagnostic and therapeutics market. Detailed
pricing analysis of different exosome diagnostic
and therapeutics across key regions is also
discussed in the research study. The segmental
analysis across North America, Western Europe,
Eastern Europe, Asia Pacific excluding Japan
(APEJ), Latin America, Japan and Middle East and
Africa (MEA) is carried out which is used to
track the future projections for a period of ten
years, pertaining to value, of the global exosome
diagnostic and therapeutics market.
5
Exosome Diagnostic and Therapeutics Market
Analysis
Global Market for Exosome Diagnostic and
Therapeutics Underlying Forces Influencing
Growth The growth of global market for exosome
diagnostics and therapeutics is influenced by
several factors. Increasing need for screening
and diagnosis of chronic diseases coupled with
high therapeutic potential of exosomes are
fuelling the adoption of exosome diagnostics and
therapeutics. Moreover, introduction of explicit
systems for analysis of proteins specific to
exosomes, increasing research and development
activities supported by favourable government
policies across various regions and increasing
popularity of exosome over CTC and ctDNA are
expected to trigger the growth of the global
market for exosome diagnostic and therapeutics
market in the years to follow. On the contrary,
lack of standardization and validation
requirements for isolation of exosomes is
expected to pose hindrances to the growth of the
global market. Other factors negatively impacting
the markets growth include heavy investments in
research and development and insufficient
insurance coverage of costly cancer diagnostic
tests. Request a Sample Report with Table of
Contents and Figures https//www.futuremarketinsi
ghts.com/reports/sample/rep-gb-6379
6
Exosome Diagnostic and Therapeutics Market
Analysis
Segmentation Highlights of the Global Exosome
Diagnostic and Therapeutics Market The global
exosome diagnostic and therapeutics market is
segmented on the basis of product type,
application, end user and region. In the region
category, North America is estimated to be the
largest with a high market lucrativeness. This
region is expected to grow at a significant CAGR
during the forecast period to touch a large
market estimation by end of the assessment year,
thus leading the global market. Moreover, Asia
Pacific excluding Japan (APEJ) is the fastest
growing region and is the second largest in terms
of adoption and use of exosome diagnostics and
therapeutics. APEJ is filled with high growth
opportunities and is being targeted by several
giants in this sector, such as Thermo Fisher
Scientific.
By product type, reagents and kits are gaining
high traction owing to increasing use in exosome
diagnostics and therapeutics. The reagents and
kits segment dominated the market in 2017 and is
anticipated to continue with the trend in the
coming years.
7
Exosome Diagnostic and Therapeutics Market
Analysis
This segment is also expected to expand at a high
growth rate during the forecast period. The
reagents and kits segment is expected to register
a high CAGR of 28.2 throughout the period of
forecast. The software segment is the second
fastest growing segment spurring the growth of
the global market. In the application category,
diagnostic segment is the largest as compared to
therapeutics segment and is estimated to touch a
value of over US 90 Mn by the end of the year of
assessment, growing at a significant pace.
Therapeutics segment is projected to expand at a
CAGR of 29.0 throughout the period of
assessment. With respect to end user, the use of
exosome diagnostic and therapeutics is largely
observed in diagnostic centres. The diagnostic
centres segment is expected to surpass other end
user segments with a high market share and growth
rate in the coming years.
8
Exosome Diagnostic and Therapeutics Market
Analysis
Our advisory services are aimed at helping you
with specific, customised insights that are
relevant to your specific challenges. Let us know
about your challenges and our trusted advisors
will connect with you https//www.futuremarketins
ights.com/askus/rep-gb-6379 Forecast Analysis of
the Global Exosome Diagnostic and Therapeutics
Market According to the research report, the
global market for exosome diagnostic and
therapeutics is expected to grow at a high CAGR
to reach an estimate of over US 150 Mn by the
end of the year of assessment from a value of
about US 19 Mn in 2017.
9
Exosome Diagnostic and Therapeutics Market
Analysis
Competitive Landscape Shaping the Global Exosome
Diagnostic and Therapeutics Market Manufacturers
of exosome diagnostic and therapeutics are
focusing to raise capital required for launch of
new products or research and development expenses
through venture financing. Key companies such as
Thermo Fisher Scientific, Inc., NanoSomix, Inc.,
NX PHARMAGEN, Capricor Therapeutics, Inc.,
Exosome Diagnostics, Inc., Exiqon A/S (Aethlon
Medical, Inc.)., System Biosciences, Inc., Aegle
Therapeutics AMS Biotechnology (Europe) Limited
and Miltenyi Biotec. Preview Analysis Global
Exosome Diagnostic and Therapeutics Market
Segmentation By Product Type - Instrument,Software
,Reagents and,Kits By Application Type -
Diagnostics,Therapeutics By End User Type -
Hospitals,Cancer Institutes,Diagnostic
Centres https//www.futuremarketinsights.com/repo
rts/exosome-diagnostic-and-therapeutics-market
10
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)